MediMedia Managed Markets, an ICON Company, Wins Two Gold Industry Awards for Data Analytics and Healthcare Communications
November 16 2017 - 5:00AM
Business Wire
ICON plc, (NASDAQ: ICLR)) a global provider of drug
development solutions and services to the pharmaceutical,
biotechnology and medical device industries, today announced that
MediMedia Managed Markets, an ICON company, has received two gold
industry awards in recognition of innovative customer
solutions.
MediMedia was awarded gold for the Best Use of Data Analytics at
the 2017 Medical Marketing & Media (MM&M) Healthcare
Awards. The award recognised MediMedia’s work on a stakeholder
mapping and segmentation project for a pharma customer, which
involved mapping hospitals to health systems, integrated delivery
networks, group purchasing organisations and accountable care
organisations (ACOs). MediMedia developed a fully integrated data
ecosystem, including data from 17 sources, that provided visibility
across all customer types and standardised performance measurement
and reporting. The analysis and supporting data ultimately helped
to refine brand market access strategy; revise sales alignment; and
develop resources for underperforming segments. Results included
expanded inpatient formulary coverage and improved utilisation
rates with both system-affiliated and ACO-affiliated consumers.
MediMedia also won gold in the Digital Media Mobile App category
at the 2017 MarCom Awards, a global awards programme that honours
excellence in marketing and communication. MediMedia was a winner
for developing a Local Care Center Finder App for Otsuka America
Pharmaceutical Inc. The app, which is part of Otsuka’s ASSURE
Program™, helps patients find alternate locations, such as retail
pharmacies and infusion centers, where they can receive their
prescribed injection from a licensed healthcare professional.
In addition to the two gold awards, Jodie McVan, Head Creative
Services, Global Access, Commercialisation and Communications, has
also been selected as a finalist in the 2017 Stevie Awards for
Women in Business. More than 1,500 entries were submitted in 2017
and Jodie was selected as a finalist in the Woman of the Year -
Advertising, Marketing & Public Relations category. Winners
will be announced at a ceremony in New York on 14 November.
Commenting on the awards, Ramita Tandon, EVP, ICON
Commercialisation & Outcomes, said: “We are honoured to be
recognised as the industry’s best for mapping key stakeholders to
support Market Access strategies and improving product utilisation.
ICON provides the real world evidence-based expertise, insights,
and tools to leverage our deeper understanding of patient
experiences and priorities, while accelerating market access for
products that are truly aligned to patient, payer, and provider
demands.”
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 97 locations in 38 countries and has approximately
13,100 employees.
Further information is available at www.iconplc.com
ICON/ICLR-G
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171116005080/en/
ICON Press Office EnquiriesWeber ShandwickOlivia
PimentaEmail: LDNWSWICONClinical@corp.ipgnetwork.com
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Apr 2024 to May 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From May 2023 to May 2024